Earnings History Data for Gain Therapeutics (GANX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Gain Therapeutics
Gain Therapeutics Inc. is redefining drug discovery with its See-Tx(TM) target identification platform. It involved in identifying and optimizing allosteric binding sites which have never before been targeted. The company is unlocking new treatment options for difficult-to-treat disorders characterized by protein misfolding. Gain Therapeutics Inc. is based in BETHESDA, Md.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26-03-2024 | PM | GANX | Gain Therapeutics | 52.00 | -0.29 | -0.32 | 0.00 | Gain Therapeutics GAAP EPS of -$1.71 misses by $0.14, revenue of $0.05M misses by $0.25M [3/26/2024 3:26 PM] |
3.85 | 0.20 (5.48%) |
0.0 | 0.0 (0.00%) |
2.00 - 6.19 | 141,231 | 140,000 | 0 | ||
| 14-11-2023 | PM | GANX | Gain Therapeutics | 35.00 | -0.37 | -0.47 | 0.00 | Gain Therapeutics GAAP EPS of -$0.37 [11/14/2023 9:02 AM] |
2.71 | -0.08 (-2.86%) |
2.76 | -0.03 (-1.08%) |
2.56 - 6.19 | 36,856 | 30,000 | 2,017 | ||
| 10-08-2023 | PM | GANX | Gain Therapeutics | 46.00 | -0.62 | -0.33 | 0.00 | Gain Therapeutics GAAP EPS of -$0.62 [8/10/2023 10:31 AM] |
3.58 | -0.17 (-4.67%) |
0.0 | 0.0 (0.00%) |
2.80 - 6.19 | 32,652 | 60,000 | 0 | ||
| 12-05-2023 | PM | GANX | Gain Therapeutics | 63.00 | -0.43 | -0.40 | 0.00 | Gain Therapeutics GAAP EPS of -$0.43, revenue of $0.06M [5/12/2023 9:06 AM] |
5.12 | -0.03 (-0.58%) |
0.0 | 0.0 (0.00%) |
2.33 - 6.19 | 75,465 | 60,000 | 0 | ||
| 10-11-2022 | AH | GANX | Gain Therapeutics | 37.00 | -0.38 | -0.46 | 0.00 | Gain Therapeutics GAAP EPS of -$0.38 beats by $0.08 [11/10/2022 4:54 PM] |
3.22 | 0.05 (1.58%) |
0.0 | 0.0 (0.00%) |
2.33 - 9.70 | 37,681 | 20,000 | 0 | ||
| 08-08-2022 | PM | GANX | Gain Therapeutics | 47.00 | -0.43 | -0.35 | 0.00 | 4.22 | 0.21 (5.24%) |
0.0 | 0.0 (0.00%) |
2.33 - 9.75 | 34,346 | 50,000 | 0 | |||
|
|
||||||||||||||||||
| 24-03-2022 | PM | GANX | Gain Therapeutics | 52.00 | -0.25 | -0.49 | 0.00 | Gain Therapeutics GAAP EPS of -$1.37 beats by $0.25, revenue of $0.16M beats by $0.01M [3/24/2022 9:29 AM] |
4.50 | 0.08 (1.81%) |
0.0 | 0.0 (0.00%) |
2.98 - 17.93 | 47,297 | 55,452 | 0 | ||
| 12-11-2021 | PM | Before the open (Nov 12) |
GANX | Gain Therapeutics | 93.00 | -0.39 | -0.34 | 0.00 | Gain Therapeutics EPS misses by $0.03 [11/12/2021 8:06 AM] |
8.25 | 0.77 (10.29%) |
0.0 | 0.0 (0.00%) |
6.50 - 17.93 | 202,383 | 80,000 | 0 | |
|
||||||||||||||||||
| 11-08-2021 | AH | GANX | Gain Therapeutics, Inc. | 94.00 | -0.30 | -0.31 | 0.00 | Gain Therapeutics Q2 EPS in-line [8/11/2021 5:04 PM] |
7.70 | -0.10 (-1.28%) |
0.0 | 0.0 (0.00%) |
7.61 - 17.93 | 21,832 | 20,000 | 0 | ||